IL-1α and IL-1ra secretion from epidermal equivalents and the prediction of the irritation potential of mild soap and surfactant-based consumer products

Toxicology in Vitro

Volumn 13, Issue 2, 1999, Pages 231-239

  Bernhofer, L P ^a   Barkovic, S ^b   Appa, Y ^b   Martin, K M ^a  

^a Skin Biology Research Center   (United States)

^b Neutrogena Corporation   (United States)

Author keywords

Clinical results; Consumer products; Correlation in vitro clinical; IL 1 ; IL 1ra; ; In vitro; Irritation; Skin equivalent; Surfactants

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SOAP; SURFACTANT;

ARTICLE; BIOLOGICAL MODEL; CELL VIABILITY; CYTOKINE RELEASE; EPIDERMIS; HUMAN; HUMAN TISSUE; PREDICTION; SAFETY; SKIN IRRITATION;

EID: 0033038004     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(98)00088-5     Document Type: Article

References (20)

1. Balls M., DeKlerck W., Baker F., van Beek M., Bouillon C., Bruner L., Carstensen J., Chamberlain M., Cottin M., Curren R., Dupuis J., Fairweather F., Faure U., Fentem J., Fisher C., Galli C., Kemper F., Knaap A., Langley G., Loprieno G., Loprieno N., Pape W., Pechovitch G., Spielmann H., Ungar K., White I., Zuang V. Development and Validation of Non-animal Tests and Testing Strategies: the Identification of a Coordinated Response to the Challenge and the Opportunity Presented by the Sixth Amendment to the Cosmetics Directive (76/768/EEC) The Report and Recommendations of an ECVAM/CPPS Workshop (ECVAM Workshop 7). ATLA. 23:1995;398-409.
2. Balls M., Goldberg A.M., Fentem J.H., Broadhead C.L., Burch R.L., Festing M.F.W., Frazier J.M., Hendriksen C.F.M., Jennings M., van der Kamp M.D.O., Morton D.B., Rowan A.N., Russell C., Russell W.M.S., Speilmann H., Stephens M.L., Stokes W.S., Straughan D.W., Yager J.D., Zurlo J., van Zutphen B.F.M. The Three Rs: The Way Forward, The Report and Recommendations of ECVAM Workshop 11. ATLA. 23:1995;838-866.
3. Bernhofer L., Seiberg M., Martin K.M. The influence of the response of skin equivalent systems to topically applied consumer products by epithelial-mesenchymal interactions. Toxicology in Vitro. 13:1999;219-229.
4. 2TM. Toxicology in Vitro. 10:1996;513-521.
5. Cannon C. L., Neal P. J., Kubilus J. and Klausner M. (1993) MatTek Corp, 200 Homer Ave, Ashland, MA 01721. USA. Initial Characterization Of A New Model For Dermal Irritancy Testing. Tissue Culture Association annual meeting, (June), San Diego, CA.
6. Dinarello C.A. (1997) Induction of interleukin-1 receptor antagonist. Seminars in Oncology 24 (Suppl. 9), S9-81-S9-93.
7. Draize J.H., Woodard G., Calvery H.O. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of Pharmacology and Experimental Therapeutics. 82:1944;377-390.
8. Dykes P.J., Edwards M.J., O'Donovan M.R., Merrett V., Morgan H.E., Marks R. In Vitro reconstruction of human skin: the use of skin equivalents as potential indicators of cutaneous toxicity. Toxicology in Vitro. 5:1991;1-8.
9. Elmets C.A. Progress in the development of an in vitro assay for contact allergens: results of the Avon project experience. In Vitro Toxicology. 9:1996;223-235.
10. Herzinger T., Korting H.C., Maibach H.I. Review - Assessment of cutaneous and ocular irritancy: a decade of research on alternatives to animal experimentation. Fundamental and Applied Toxicology. 24:1995;29-41.
11. Kubilus J., Cannon C.L., Neal P.J., Ricker H.A., Klausner M. Cytokine response of the EpiDerm skin model to topically applied irritants and toxicants. In Vitro Toxicology. 9:1996;157.
12. Kupper T.S., Groves R.W. The interleukin-1 axis and cutaneous inflammation. Journal of Investigative Dermatology. 105:(Suppl.):1995;62S-66S.
13. Lennard A.C. Interleukin-1 receptor antagonist. Critical Reviews in Immunology. 15:1995;77-105.
14. Li D.Q., Tseng S.C. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. Journal of Cell Physiology. 163:1995;61-79.
15. Müller-Decker K., Fürstenberger G., Marks F. Development of an in vitro alternative assay to the Draize skin irritancy test using human keratinocyte-derived proinflammatory mediators and cell viability as test parameters. In Vitro Toxicology. 5:1992;191-209.
16. Nicoll G.A., Murahata R.I., Grove G.L., Barrows J., Sharko P.T. The relative sensitivity of two arm-wash methods for evaluating the mildness of personal washing products. Journal of the Society of Cosmetic Chemists. 46:1995;129-140.
17. Ponec M., Kempenaar J. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacology. 8:1995;49-59.
18. Sauder D.N., Pastore S. Cytokines in contact dermatitis. American Journal of Contact Dermatitis. 4:1993;215-224.
19. Slivka S.R., Zeigler F. Use of an in vitro skin model for determining epidermal and dermal contributions to irritant responses. Journal of Toxicology-Cutaneous and Ocular Toxicology. 12:1993;49-57.
20. Walker A.P., Basketter D.A., Baverel M., Diembeck W., Matthies W., Mougin D., Paye M., Röthlisberger R., Dupuis J. Test guidelines for assessment of skin compatibility of cosmetic finished products in man. Food and Chemical Toxicology. 34:1996;651-660.